Search research articles
Contact Us
Filters
Showing results (81-90 of 129) with videos related to
Page
of 13
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 3, 2018
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study
Gavin Giovannoni, Per Soelberg Sorensen, Stuart Cook, et al.
Plos One
|
November 10, 2010
Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown
Axel Haarmann, Annika Deiss, Jürgen Prochaska, et al.
Journal of Neurology
|
July 25, 2009
Symptomatology of MS: results from the German MS Registry
Kristin Stuke, Peter Flachenecker, Uwe K Zettl, et al.
Therapeutic Advances in Neurological Disorders
|
July 9, 2020
Expert opinion on the use of cladribine tablets in clinical practice
Per Soelberg Sørensen, Diego Centonze, Gavin Giovannoni, et al.
Multiple Sclerosis and Related Disorders
|
March 20, 2019
Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis
Giancarlo Comi, Stuart Cook, Gavin Giovannoni, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 29, 2010
Functional role of ipsilateral motor areas in multiple sclerosis
Daniel Zeller, Su-Yin Dang, Katja Stefan, et al.
Infection and Immunity
|
November 24, 2004
Downregulation of CXCR1 and CXCR2 expression on human neutrophils by Helicobacter pylori: a new pathomechanism in H. pylori infection?
Bernd Schmausser, Christine Josenhans, Simon Endrich, et al.
Journal of Neuroimmunology
|
October 7, 2004
The role of the polio virus receptor and the herpesvirus entry mediator B genes for the development of MS
Berit Rosche, Sabine Cepok, Susanne Stei, et al.
Journal of Neurology
|
May 17, 2005
Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosis
Peter Rieckmann, N Kruse, L Nagelkerken, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
July 16, 2005
Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis
Susanne Vogler, René Goedde, Bianca Miterski, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 129) with videos related to
Sort By:
Page
of 13
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 3, 2018
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study
Gavin Giovannoni, Per Soelberg Sorensen, Stuart Cook, et al.
Plos One
|
November 10, 2010
Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown
Axel Haarmann, Annika Deiss, Jürgen Prochaska, et al.
Journal of Neurology
|
July 25, 2009
Symptomatology of MS: results from the German MS Registry
Kristin Stuke, Peter Flachenecker, Uwe K Zettl, et al.
Therapeutic Advances in Neurological Disorders
|
July 9, 2020
Expert opinion on the use of cladribine tablets in clinical practice
Per Soelberg Sørensen, Diego Centonze, Gavin Giovannoni, et al.
Multiple Sclerosis and Related Disorders
|
March 20, 2019
Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis
Giancarlo Comi, Stuart Cook, Gavin Giovannoni, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 29, 2010
Functional role of ipsilateral motor areas in multiple sclerosis
Daniel Zeller, Su-Yin Dang, Katja Stefan, et al.
Infection and Immunity
|
November 24, 2004
Downregulation of CXCR1 and CXCR2 expression on human neutrophils by Helicobacter pylori: a new pathomechanism in H. pylori infection?
Bernd Schmausser, Christine Josenhans, Simon Endrich, et al.
Journal of Neuroimmunology
|
October 7, 2004
The role of the polio virus receptor and the herpesvirus entry mediator B genes for the development of MS
Berit Rosche, Sabine Cepok, Susanne Stei, et al.
Journal of Neurology
|
May 17, 2005
Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosis
Peter Rieckmann, N Kruse, L Nagelkerken, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
July 16, 2005
Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis
Susanne Vogler, René Goedde, Bianca Miterski, et al.
Page
of 13